US FDA approves AstraZeneca’s immunotherapy for lung cancer – Reuters
Reuters |
US FDA approves AstraZeneca's immunotherapy for lung cancer
Reuters (Reuters) – The U.S. Food and Drug Administration on Friday granted approval for expanded use of AstraZeneca Plc's, immunotherapy drug, Imfinzi, to treat non-small cell lung cancer whose tumors can't be surgically removed. FILE PHOTO: A sign is seen at … |
